Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Cutting edge: Dendritic cells prime a high avidity CTL response independent of the level of presented antigen
Charles J Kroger, Samuel Amoah, Martha A Alexander-Miller
Frontiers in Immunology
|
February 19, 2021
The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes
Matthew Clark, Charles J Kroger, Qi Ke, et al.
Cellular Immunology
|
May 12, 2004
High avidity CD8+ T cells generated from CD28-deficient or wildtype mice exhibit a differential dependence on lipid raft integrity for activation
Andrew G Cawthon, Charles J Kroger, Martha A Alexander-Miller
Frontiers in Immunology
|
March 8, 2021
Evolving Antibody Therapies for the Treatment of Type 1 Diabetes
Qi Ke, Charles J Kroger, Matthew Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 30, 2016
Thymic Dendritic Cell Subsets Display Distinct Efficiencies and Mechanisms of Intercellular MHC Transfer
Charles J Kroger, Nicholas A Spidale, Bo Wang, et al.
Frontiers in Immunology
|
September 1, 2018
Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
Charles J Kroger, Matthew Clark, Qi Ke, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
September 28, 2010
Dysregulation of thymic clonal deletion and the escape of autoreactive T cells
Charles J Kroger, Rafael R Flores, Maurice Morillon, et al.
Advanced Healthcare Materials
|
July 28, 2018
Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31
Naihan Chen, Charles J Kroger, Roland M Tisch, et al.
Bone
|
February 14, 2004
Discrimination between cases of hip fracture and controls is improved by hip structural analysis compared to areal bone mineral density. An ex vivo study of the femoral neck
P Mayhew, S Kaptoge, N Loveridge, et al.
JCI Insight
|
July 27, 2021
Coreceptor therapy has distinct short- and long-term tolerogenic effects intrinsic to autoreactive effector T cells
Matthew Clark, Charles J Kroger, Qi Ke, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Journal of Immunology (Baltimore, Md. : 1950)
|
April 22, 2008
Cutting edge: Dendritic cells prime a high avidity CTL response independent of the level of presented antigen
Charles J Kroger, Samuel Amoah, Martha A Alexander-Miller
Frontiers in Immunology
|
February 19, 2021
The Role of T Cell Receptor Signaling in the Development of Type 1 Diabetes
Matthew Clark, Charles J Kroger, Qi Ke, et al.
Cellular Immunology
|
May 12, 2004
High avidity CD8+ T cells generated from CD28-deficient or wildtype mice exhibit a differential dependence on lipid raft integrity for activation
Andrew G Cawthon, Charles J Kroger, Martha A Alexander-Miller
Frontiers in Immunology
|
March 8, 2021
Evolving Antibody Therapies for the Treatment of Type 1 Diabetes
Qi Ke, Charles J Kroger, Matthew Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 30, 2016
Thymic Dendritic Cell Subsets Display Distinct Efficiencies and Mechanisms of Intercellular MHC Transfer
Charles J Kroger, Nicholas A Spidale, Bo Wang, et al.
Frontiers in Immunology
|
September 1, 2018
Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes
Charles J Kroger, Matthew Clark, Qi Ke, et al.
Archivum Immunologiae Et Therapiae Experimentalis
|
September 28, 2010
Dysregulation of thymic clonal deletion and the escape of autoreactive T cells
Charles J Kroger, Rafael R Flores, Maurice Morillon, et al.
Advanced Healthcare Materials
|
July 28, 2018
Prevention of Type 1 Diabetes with Acetalated Dextran Microparticles Containing Rapamycin and Pancreatic Peptide P31
Naihan Chen, Charles J Kroger, Roland M Tisch, et al.
Bone
|
February 14, 2004
Discrimination between cases of hip fracture and controls is improved by hip structural analysis compared to areal bone mineral density. An ex vivo study of the femoral neck
P Mayhew, S Kaptoge, N Loveridge, et al.
JCI Insight
|
July 27, 2021
Coreceptor therapy has distinct short- and long-term tolerogenic effects intrinsic to autoreactive effector T cells
Matthew Clark, Charles J Kroger, Qi Ke, et al.
Page
of 4